Drug Discovery News and Research

RSS
The drug discovery process begins with recognizing a disease or clinical condition in which there is a lack of adequate medical treatment. Once a potential drug has been identified, pre-clinical research can begin. This process includes several stages; the first of which involves identifying and validating the prospective drug’s target through assay development, high throughput screening, hit identification and finally, lead optimization. Once the pre-clinical process is complete, the newly synthesized drug candidate is selected for future clinical development.
Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

Future likely to witness improved therapies and novel drugs to treat lifestyle disorders

FORMA Therapeutics closes Series B financing to a total of $25.5 million

FORMA Therapeutics closes Series B financing to a total of $25.5 million

UC3M researchers developing a prototype for extracting drug interactions

UC3M researchers developing a prototype for extracting drug interactions

European Patent Office grants patent EP1392642 for 4SC AG's lead auto-immune compound

European Patent Office grants patent EP1392642 for 4SC AG's lead auto-immune compound

Merck to commence MK-6913 phase IIa efficacy trial for treatment of hot flashes/hot flushes

Merck to commence MK-6913 phase IIa efficacy trial for treatment of hot flashes/hot flushes

Researchers uncover atomic-level action of ring-shaped protein motors

Researchers uncover atomic-level action of ring-shaped protein motors

Oxagen completes £16 Million Series C round funding

Oxagen completes £16 Million Series C round funding

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

DSS sets evidence-based guidelines and definitions to treat type 2 diabetes

New technology developed to rapidly identify compounds for the treatment of heart failure

New technology developed to rapidly identify compounds for the treatment of heart failure

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Jubilant Organosys, UAB and Southern Research Institute announce joint venture to accelerate global drug development

Asterand extends its collaboration agreement with Bristol-Myers Squibb

Asterand extends its collaboration agreement with Bristol-Myers Squibb

Isis Pharmaceuticals CEO's letter to shareholders

Isis Pharmaceuticals CEO's letter to shareholders

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Positive interim results from Nereus Pharmaceuticals' plinabulin VDA study for advanced NSCLC

Receptos raises $25 million through Series A financing

Receptos raises $25 million through Series A financing

Bio-Quant to be acquired by NexMed

Bio-Quant to be acquired by NexMed

ASTMH symposium illustrates the need to generate new medicines for infectious diseases

ASTMH symposium illustrates the need to generate new medicines for infectious diseases

Alzheimer Research Forum reports on the highlights of the Society of Neuroscience conference

Alzheimer Research Forum reports on the highlights of the Society of Neuroscience conference

CDAS, Prestwick Chemical sign drug discovery research agreement

CDAS, Prestwick Chemical sign drug discovery research agreement

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Ligand Pharmaceuticals receives $2 million in milestone payments from N. V. Organon

Ligon Discovery raises $1 million

Ligon Discovery raises $1 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.